Alector, Inc. (ALEC) vs ARS Pharmaceuticals, Inc. (SPRY)
- Alector, Inc. ALEC 2.47 −6.08%
- ARS Pharmaceuticals, Inc. SPRY 3.84 −2.78%
Alector, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Alector, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($397.1M and $391.6M). ARS Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 7.0×. Alector, Inc. grew revenue faster over the last twelve months: 151.2% against −14.5%. Alector, Inc. has the higher net margin (23.9% vs −163.7%) and the higher return on invested capital (0.00% vs −264.0%). Across the 16 metrics below, Alector, Inc. leads on 13 and ARS Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ALEC | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 71.03% | 68.27% |
| Operating margin | 20.16% | (161.50%) | 0.00% |
| Net margin | 23.87% | (163.66%) | 0.00% |
| Free cash flow margin | (86.31%) | (149.89%) | 0.00% |
| Return on equity | 47.52% | (294.60%) | (50.82%) |
| Return on assets | 16.53% | (64.04%) | (46.08%) |
| Return on invested capital | 0.00% | (263.95%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack